CN117625527A - Method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, composition and application - Google Patents
Method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, composition and application Download PDFInfo
- Publication number
- CN117625527A CN117625527A CN202311756120.XA CN202311756120A CN117625527A CN 117625527 A CN117625527 A CN 117625527A CN 202311756120 A CN202311756120 A CN 202311756120A CN 117625527 A CN117625527 A CN 117625527A
- Authority
- CN
- China
- Prior art keywords
- differentiation
- medium
- cell
- precursor cells
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002243 precursor Substances 0.000 title claims abstract description 75
- 238000000034 method Methods 0.000 title claims abstract description 58
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 230000002293 adipogenic effect Effects 0.000 title claims description 7
- 210000004027 cell Anatomy 0.000 claims abstract description 144
- 230000004069 differentiation Effects 0.000 claims abstract description 88
- 230000009815 adipogenic differentiation Effects 0.000 claims abstract description 41
- 210000001789 adipocyte Anatomy 0.000 claims abstract description 35
- 235000013372 meat Nutrition 0.000 claims abstract description 24
- 241000124008 Mammalia Species 0.000 claims abstract description 8
- 238000000338 in vitro Methods 0.000 claims abstract description 8
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 claims description 85
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 74
- 235000019197 fats Nutrition 0.000 claims description 63
- 239000002609 medium Substances 0.000 claims description 56
- 239000001963 growth medium Substances 0.000 claims description 52
- 239000012091 fetal bovine serum Substances 0.000 claims description 51
- 239000008055 phosphate buffer solution Substances 0.000 claims description 45
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 43
- 229960004586 rosiglitazone Drugs 0.000 claims description 41
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical group [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 claims description 40
- 102000004877 Insulin Human genes 0.000 claims description 39
- 108090001061 Insulin Proteins 0.000 claims description 39
- 229940125396 insulin Drugs 0.000 claims description 37
- 239000000243 solution Substances 0.000 claims description 35
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 28
- 238000010186 staining Methods 0.000 claims description 26
- 238000005406 washing Methods 0.000 claims description 23
- 229960003957 dexamethasone Drugs 0.000 claims description 22
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 22
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 21
- 239000000194 fatty acid Substances 0.000 claims description 21
- 229930195729 fatty acid Natural products 0.000 claims description 21
- 239000011734 sodium Substances 0.000 claims description 21
- 229910052708 sodium Inorganic materials 0.000 claims description 21
- ZOBPZXTWZATXDG-UHFFFAOYSA-N 1,3-thiazolidine-2,4-dione Chemical compound O=C1CSC(=O)N1 ZOBPZXTWZATXDG-UHFFFAOYSA-N 0.000 claims description 20
- 229940123464 Thiazolidinedione Drugs 0.000 claims description 20
- 239000007640 basal medium Substances 0.000 claims description 20
- 239000003862 glucocorticoid Substances 0.000 claims description 19
- 238000012423 maintenance Methods 0.000 claims description 19
- 230000001737 promoting effect Effects 0.000 claims description 17
- -1 sodium fatty acid Chemical class 0.000 claims description 16
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 14
- 150000002632 lipids Chemical class 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 102000029816 Collagenase Human genes 0.000 claims description 13
- 108060005980 Collagenase Proteins 0.000 claims description 13
- 229960002424 collagenase Drugs 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 102100036467 Protein delta homolog 1 Human genes 0.000 claims description 12
- 238000010494 dissociation reaction Methods 0.000 claims description 12
- 230000005593 dissociations Effects 0.000 claims description 12
- 238000010166 immunofluorescence Methods 0.000 claims description 12
- 238000002955 isolation Methods 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 claims description 11
- 230000029087 digestion Effects 0.000 claims description 11
- 101150102995 dlk-1 gene Proteins 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- 210000001519 tissue Anatomy 0.000 claims description 11
- 238000004113 cell culture Methods 0.000 claims description 9
- 238000004043 dyeing Methods 0.000 claims description 9
- 150000004665 fatty acids Chemical class 0.000 claims description 9
- 239000012192 staining solution Substances 0.000 claims description 9
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 8
- 238000011161 development Methods 0.000 claims description 8
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- 239000013049 sediment Substances 0.000 claims description 8
- 229960001641 troglitazone Drugs 0.000 claims description 8
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 claims description 8
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 claims description 8
- 238000001262 western blot Methods 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 7
- 238000005516 engineering process Methods 0.000 claims description 7
- 229960000890 hydrocortisone Drugs 0.000 claims description 7
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 7
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 6
- 239000013592 cell lysate Substances 0.000 claims description 6
- 102100030431 Fatty acid-binding protein, adipocyte Human genes 0.000 claims description 5
- 101001062864 Homo sapiens Fatty acid-binding protein, adipocyte Proteins 0.000 claims description 5
- 230000000903 blocking effect Effects 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 230000001939 inductive effect Effects 0.000 claims description 5
- 230000004060 metabolic process Effects 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 102100031786 Adiponectin Human genes 0.000 claims description 4
- 241000283707 Capra Species 0.000 claims description 4
- 101000775469 Homo sapiens Adiponectin Proteins 0.000 claims description 4
- 108010016731 PPAR gamma Proteins 0.000 claims description 4
- 210000003855 cell nucleus Anatomy 0.000 claims description 4
- 230000001413 cellular effect Effects 0.000 claims description 4
- 230000001079 digestive effect Effects 0.000 claims description 4
- 210000003743 erythrocyte Anatomy 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 238000011534 incubation Methods 0.000 claims description 4
- 239000003550 marker Substances 0.000 claims description 4
- 238000000197 pyrolysis Methods 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000012224 working solution Substances 0.000 claims description 4
- 102100034808 CCAAT/enhancer-binding protein alpha Human genes 0.000 claims description 3
- 101000945515 Homo sapiens CCAAT/enhancer-binding protein alpha Proteins 0.000 claims description 3
- 206010049287 Lipodystrophy acquired Diseases 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 3
- 239000000411 inducer Substances 0.000 claims description 3
- 208000006132 lipodystrophy Diseases 0.000 claims description 3
- 238000005259 measurement Methods 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 235000019737 Animal fat Nutrition 0.000 claims description 2
- 238000000116 DAPI staining Methods 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 238000010297 mechanical methods and process Methods 0.000 claims description 2
- 239000002244 precipitate Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 102000000536 PPAR gamma Human genes 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000024245 cell differentiation Effects 0.000 abstract description 11
- 241001465754 Metazoa Species 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000003925 fat Substances 0.000 description 54
- 241000282898 Sus scrofa Species 0.000 description 26
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 18
- 239000000306 component Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 4
- 238000007865 diluting Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000035800 maturation Effects 0.000 description 4
- 235000015277 pork Nutrition 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 102100038825 Peroxisome proliferator-activated receptor gamma Human genes 0.000 description 3
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 3
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000009482 thermal adhesion granulation Methods 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 239000000834 fixative Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000007790 scraping Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 230000000304 vasodilatating effect Effects 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 101000928535 Homo sapiens Protein delta homolog 1 Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229940082638 cardiac stimulant phosphodiesterase inhibitors Drugs 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000020993 ground meat Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003520 lipogenic effect Effects 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 210000002464 muscle smooth vascular Anatomy 0.000 description 1
- 238000012758 nuclear staining Methods 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 210000000463 red nucleus Anatomy 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000013333 regulation of fatty acid metabolic process Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0653—Adipocytes; Adipose tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
- C12N2509/10—Mechanical dissociation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the technical field of in-vitro differentiation of cells, and provides a method and a composition for separating, identifying and adipogenic differentiation of fat precursor cells of mammals and application thereof. The results show that the adipogenic differentiation method has good beneficial effects, is an ideal method for researching the differentiation of fat cells, and has important application value for the fields of animal husbandry, biomedicine and biological cultivation meat.
Description
Technical Field
The invention belongs to the technical field of in-vitro cell differentiation, and particularly relates to a method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, a composition and application thereof.
Background
With the increasing interest in sustainable foods and animal welfare, biological breeding meats are receiving increasing attention as a potential alternative. The biological cultivated meat is also called cultivated meat, cell cultivated meat, clean meat and the like, and is a novel meat food which is formed by controlling the rapid proliferation, directional differentiation and collecting and processing of animal cells in an in-vitro culture mode. Wherein the development of animal adipose tissue and the differentiation of adipose cells are of great significance to the research of meat quality and diseases.
In the traditional animal husbandry, the quality and fat content of pork are generally affected by pig breeds and feeding conditions, and the development process of pig fat cells can be controlled and regulated more accurately by using a fat cell differentiation technology, so that fine regulation and control of the meat quality are realized, the consistency and quality of the meat quality are improved, and the market demands of different types of pork are met. For example, by promoting the differentiation of pig fat precursor cells, the fat content in pork can be increased, the meat quality can be improved, and the pork is more suitable for the taste demands of consumers, so that high-quality meat cells can be produced under in vitro conditions, and a foundation is provided for the production of biological cultured meat.
Methods have been used to promote differentiation of porcine adipocytes, such as medium compositions, gene regulation methods, and small molecule compounds. However, these methods have some limitations such as stability, inefficiency, side effects, and the like. For example, a common method of mammalian adipocyte differentiation is the Cocktail method (Cocktail), specifically a hormonal mixture of Insulin (INS), dexamethasone (DEX) and 3-isobutyl-1-methylxanthine (IBMX). However, the method has low differentiation efficiency, uneven differentiation and poor stability. Thus, there is a need for a more efficient and viable method to overcome these technical problems, thereby promoting differentiation and maturation of porcine fat precursor cells.
The specification of China invention CN202210418352.3 describes a preparation method of yak precursor fat cells, wherein the kidney week and subcutaneous fat of calf in one week of birth are subjected to primary culture in vitro by a type I collagenase digestion method, low-concentration pancreatin digestion and microscopic observation are combined with physical shock to perform subculture, and an induced differentiation culture medium is modified to perform induced differentiation culture, so that mature yak fat cells are obtained. The cell obtained by the patent has good morphology, fast cell proliferation and efficient induced differentiation treatment, is a more effective precursor fat cell culture method, and provides a necessary carrier for researching the molecular mechanism of yak body fat deposition.
The above methods have a certain effect, but the differentiation efficiency, differentiation uniformity and stability still need to be improved, and a separation and differentiation method with few side effects is also currently required.
Disclosure of Invention
In order to solve the technical problems, the invention provides a method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, a composition and application thereof, and the method has the advantages of high differentiation efficiency, uniform differentiation, good stability and few side effects; the operation method is simple and efficient to realize the differentiation and maturation of the pig fat cells.
A method for the isolation, identification and adipogenic differentiation of mammalian adipose precursor cells solving the above technical problems, comprising the steps of:
step one, isolating mammalian fat precursor cells: using a mechanical method in combination with a collagenase digestion method;
step two, identifying the mammalian fat precursor cells: using cellular immunofluorescence;
step two, lipogenic induction for promoting in vitro differentiation of mammalian fat precursor cells: inducing adipogenic differentiation of the adipose precursor cells into mature adipocytes by a combination of a plurality of adipogenic induction factors;
step four, identifying mature adipocytes of the mammal: identification was performed using oil red O staining, BODIPY staining, TAG (triglyceride) assay and/or Western blot techniques.
The mammal is human and other mammals, preferably other mammals are pigs, cattle, horses, sheep, mice, etc.
In an optimized scheme, the step one of separating the mammalian fat precursor cells specifically comprises the following steps:
(1) Obtaining subcutaneous fat of mammals, cutting into minced meat, adding 1-3 mg/mL collagenase solution, transferring to a tissue dissociation tube, dissociating by using a tissue dissociation device, placing in a water bath kettle at 37 ℃, digesting for 60-90 min, and dissociating once every 15-20 min; adding an equal volume of high-sugar DMEM containing 10% fetal bovine serum, stopping digestion, and filtering with a cell sieve of 70-150 μm; preferably, filtration is performed with a 100 μm cell sieve; the volume and dosage ratio of the minced meat to the collagenase solution is 1:5, a step of; wherein the collagenase is type I collagenase, and the mass concentration of the type I collagenase solution is 2 mg/mL;
(2) Centrifuging the digestive juice at 800-1500 rpm at normal temperature for 5-10 min, discarding supernatant, and retaining cell precipitate; preferably, the digest is centrifuged at 1000 rpm for 8 minutes at ambient temperature;
(3) Adding 3-5 times of volume of red blood cell lysate of minced meat into the cell sediment for resuspension, performing room temperature pyrolysis for 5-10 min, centrifuging, discarding supernatant, and reserving the cell sediment; preferably, the ice bath is not performed at room temperature;
(4) Cells were resuspended in high-glucose DMEM containing 20% FBS and then inoculated into cell culture dishes, and 10% FBS-containing high-glucose DMEM was used as complete medium after passaging.
The induction period of the method is 8 days, lipid drops appear from the next day, and then the lipid drops gradually increase and increase.
In an optimized scheme, the step two comprises the step of identifying the fat precursor cells obtained in the step one by adopting an immunofluorescence technology; preferably, the fat precursor cells in step one are characterized by cellular immunofluorescence using PREF1 as primary antibody; further preferably, the method specifically comprises the following steps:
(1) Inoculating cells into 24-well cell culture plates on the first day;
(2) The next day, the culture medium is discarded, after PBS washing, 300-500 mu L of cell fixing solution is added for fixing for 10-30 min, the fixing solution is discarded, and PBS is used for washing for 2-4 times;
(3) Adding 0.1% -1% PBSTr for cell permeation for 15-20 min, discarding PBSTr, and washing with PBS for 2-4 times;
(4) Adding 300-500 mu L of 0.2% -2% BSA, and sealing for 45-60 min at room temperature;
(5) Removing the blocking solution, adding 100-200 μl of primary PREF1 antibody (rabbit source) (dilution ratio 1:50-1:100), standing at 4deg.C overnight, and washing with PBS for 2-4 times;
(6) Adding 100-200 mu L goat anti-rabbit secondary antibody (dilution ratio is 1:100-1:200), and incubating at room temperature for 1-2 h;
(7) PBS (phosphate buffer solution) is used for washing for 2-4 times, 100-200 mu L of 1-5 mu g/mL DAPI staining solution is added for cell nucleus staining;
(8) After washing 2-4 times with PBS, observation was performed by using a fluorescence microscope and photographing was performed.
The third step specifically comprises the following steps: specific small molecule compounds are added to the cell culture medium to directly promote maturation of adipocytes:
(1) Inoculating cells to a 6-hole plate for culture, and performing two-dimensional culture; or inoculating the cells into a three-dimensional culture roller bottle 10 5 cell/mL medium, 1 piece microcarrier/10 mL medium, rotation speed set at 25 rpm,10 min;0 rpm,50 min,24 cycles, and then the rotation speed is set to be 30 rpm, and three-dimensional culture is carried out;
(2) After the cells were full (confluence reached 100%), cultivation was continued for 2 d;
(3) Changing the complete culture medium into a lipid differentiation culture medium, and inducing differentiation culture 2 d;
(4) Changing to a maintenance differentiation culture medium, and maintaining differentiation culture 2 d;
(5) Changing to complete culture medium, continuing culturing for 4 d, and changing culture medium every 2 days;
wherein the components in the adipogenic differentiation medium comprise high glucose DMEM, insulin, glucocorticoid, IBMX, thiazolidinedione, sodium fatty acid and 2-10% fetal bovine serum, and the components in the differentiation medium comprise high glucose DMEM, insulin, sodium fatty acid, thiazolidinedione and 2-10% FBS; the complete medium is 10% FBS high glucose DMEM; preferably, the thiazolidinedione is one of troglitazone and rosiglitazone, and/or the fatty acid sodium is sodium oleate, and/or the glucocorticoid is one of dexamethasone or hydrocortisone.
The induction period of the method is 8 days, lipid drops appear from the next day, and then the lipid drops gradually increase and increase.
In a further optimized scheme, the method of the invention identifies the mature adipocytes differentiated in the step (four) through oil red O staining, BODIPY staining, TAG content measurement and/or Western blot technology; preferably, the differentiated adipocytes are collected, the total cell proteins are extracted, and the expression of differentiation marker proteins ADIPOQ, FABP4, PPARgamma and CEBP alpha is detected by a Western blot technique, and TUBB and ACTB are used as internal references at the same time; preferably, BODIPY staining is used, comprising the steps of:
(1) Discarding the culture solution, and rinsing with PBS for 1-2 times;
(2) Adding cell fixing solution, fixing for 10-30 min, and rinsing with PBS for 2-4 times;
(3) Adding 1-5 mu mol/L BODIPY working solution and 1-5 mu g/mL DAPI solution, and dyeing for 10-15 min in dark place;
(4) Discarding the staining solution, and rinsing with PBS for 3 times;
(5) Observed using a fluorescence microscope and photographed.
A composition for isolation, identification and adipogenic differentiation of mammalian adipose precursor cells according to the present invention comprises insulin, IBMX, glucocorticoid, sodium fatty acid and thiazolidinedione; preferably, the thiazolidinedione is one of troglitazone and Rosiglitazone (RSG), and/or the sodium fatty acid is sodium oleate, and/or the glucocorticoid is one of Dexamethasone (DEX) or hydrocortisone; or the composition is composed of insulin, IBMX, dexamethasone, sodium oleate, and rosiglitazone.
Insulin can promote glucose in blood circulation to enter hepatic cells, muscle cells, fat cells and other tissue cells to synthesize glycogen, so that blood sugar is reduced, and synthesis of fat and protein is promoted.
Glucocorticoids are extremely important regulating molecules in the organism, play an important role in regulating the development, growth, metabolism, immune function and the like of the organism, and are the most important regulating hormones for stress response of the organism; has antiinflammatory, antitoxic, antiallergic, antishock, and nonspecific immunity inhibiting effects.
IBMX is a Phosphodiesterase (PDE) inhibitor, also known as 3-isobutyl-1-methylxanthine, which has a vasodilating effect by increasing intracellular cAMP concentration and increasing calcium ion influx by inhibiting cAMP cleavage by inhibiting phosphodiesterase F-iii which cleaves cAMP, and by producing positive myogenic effects, in addition to positive myogenic effects, phosphodiesterase inhibitors have a vasodilating effect by increasing vascular smooth muscle intracellular cAMP content.
Rosiglitazone activates PPAR-gamma nuclear receptors and is involved in the regulation of fatty acid metabolism.
Troglitazone, also known as Razilin, regulates adipocyte differentiation and lipid metabolism.
Sodium fatty acid, sodium stearyl acid, is a compound consisting of two parts, hydrophobic and hydrophilic, and is used as an anionic surfactant. Is also a triglyceride synthesis feedstock.
The invention relates to a adipogenic differentiation medium for promoting pig fat precursor cell differentiation, which comprises basic medium high-sugar DMEM, wherein the basic medium high-sugar DMEM comprises 5-10 mug/mL of insulin, 0.2-0.8 mug/mL of dexamethasone, 0.3-0.6 mmol/L of IBMX, 1-5 mug/L of rosiglitazone, 100-200 mug/L of sodium oleate and 2-10% of fetal bovine serum by taking the volume of the basic medium high-sugar DMEM as a reference; preferably, the composition contains 5. Mu.g/mL of insulin, 0.4. Mu.g/mL of dexamethasone, 0.5mmol/L of IBMX, 1. Mu. Mol/L of thiazolidinedione, 150. Mu. Mol/L of sodium fatty acid and 2-10% of fetal bovine serum; preferably, the fetal bovine serum is 10%.
The invention relates to a maintenance differentiation culture medium for promoting pig fat precursor cell differentiation, which comprises a basal medium high-sugar DMEM, wherein the basal medium high-sugar DMEM comprises 5-10 mug/mL of insulin, 1-5 mug/L of rosiglitazone, 100-200 mug/L of sodium oleate and 2-10% fetal bovine serum by taking the volume of the basal medium high-sugar DMEM as a reference; preferably, insulin is 5. Mu.g/mL, thiazolidinedione is 1. Mu. Mol/L, sodium fatty acid is 150. Mu. Mol/L and 2-10% fetal bovine serum; preferably, the fetal bovine serum is 10%.
The application of the culture medium in the invention is that the adipogenic differentiation culture medium and the maintenance differentiation culture medium are applied, and the application comprises the following steps:
(1) Mammalian fat precursor cells reached 100% confluence and continued to be cultured 2 d;
(2) Discarding the old culture medium, and adding a adipogenic differentiation culture medium to induce differentiation 2 d;
(3) Removing the adipogenic differentiation medium, and adding a maintenance differentiation medium to maintain differentiation culture 2 d;
(4) The differentiation maintaining culture medium is discarded, a complete culture medium is added, and the culture is continued for 4 d, and the culture medium is replaced every 2 d;
(5) Observed using a microscope and photographed.
The application of the composition in the invention is the application in preparing medicines or compositions for preventing, relieving and/or treating lipodystrophy, medicines for regulating and controlling fat development and metabolism, and application in a adipogenic differentiation culture medium; wherein the effective components are insulin, glucocorticoid, IBMX, thiazolidinedione and sodium fatty acid; preferably, the thiazolidinedione is one of troglitazone and rosiglitazone, and/or the fatty acid sodium is sodium oleate, and/or the glucocorticoid is one of dexamethasone or hydrocortisone.
Further to the application in preparing a kit of adipogenic differentiation additive of fat cells and a kit for improving a lipodystrophy animal model.
Further, the application in preparing the biological cultivation meat.
The application of the adipogenic differentiation culture medium comprises basal medium high sugar DMEM, fetal bovine serum, insulin, dexamethasone, IBMX, rosiglitazone and sodium oleate.
The active ingredients of the prepared medicine are a composition of insulin, dexamethasone, IBMX, rosiglitazone and sodium oleate.
The method, the composition and the application of the invention can realize the differentiation and the maturation of the mammalian fat cells under simpler and more efficient conditions; the differentiation efficiency is high, the differentiation is uniform, the stability is good, and the side effect is less; the method has a very good differentiation effect in a common culture mode such as two-dimensional culture or three-dimensional culture; can provide better tools and methods for animal husbandry, biomedical research and biological cultivation meat research, further understand the development process of the mammalian fat cells, and can be used for regulating and controlling fat development and metabolism and physiological and pathological processes related to the fat development and metabolism.
Drawings
FIG. 1 is a cell morphology of the isolated porcine fat precursor cells of example 5 of the present invention;
FIG. 2 is a graph showing the result of immunofluorescence assay of PREF1 from porcine fat precursor cells in example 5 of the present invention (note: blue is nucleus, red is PREF1 protein);
FIG. 3 is a graph showing the identification of mature adipocytes in swine of example 7 of the present invention;
fig. 4 is a graph of the measurement results of triglyceride content of differentiated 0 d and differentiated 8 d porcine adipocytes in example 7 of the present invention (p <0.001 indicates that the difference is extremely remarkable);
FIG. 5 is a graph showing the results of detection of expression of adipogenic differentiation-related genes in example 7 of the present invention;
FIG. 6 is a graph showing the results of staining lipid-forming differentiated lipid droplets in three-dimensional culture of porcine fat precursor cells in example 8 of the present invention (Scale bar:100 μm);
FIGS. 7 and 8 are graphs comparing differentiation results of 8 different adipogenic differentiation compositions of example 6 of the present invention.
Detailed Description
The invention is further illustrated by the following description of specific embodiments:
example 1 compositions for mammalian adipose precursor cell isolation, identification and adipogenic differentiation comprising insulin, IBMX, glucocorticoid, sodium fatty acid and thiazolidinedione;
in this embodiment, the thiazolidinedione is one of troglitazone and Rosiglitazone (RSG), and/or the fatty acid sodium is sodium oleate, and/or the glucocorticoid is one of Dexamethasone (DEX) or hydrocortisone; or the composition is composed of insulin, IBMX, glucocorticoid, sodium oleate and rosiglitazone.
Further, the culture medium for promoting the differentiation of the fat precursor cells comprises the following components in parts by weight: the basal medium, high glucose DMEM, contains 5 μg/mL insulin, 0.4 μg/mL dexamethasone, 0.5mmol/L IBMX, 1 μmol/L rosiglitazone, 150 μmol/L sodium oleate and 2% fetal bovine serum.
The maintenance differentiation culture medium for promoting pig fat precursor cell differentiation comprises the following components in parts by weight: the basal medium, high sugar DMEM, contains 5 μg/mL insulin, 1 μmol/L rosiglitazone, 150 μmol/L sodium oleate and 2% fetal bovine serum based on the basal medium.
Example 2 a medium for the isolation, identification and adipogenic differentiation of mammalian adipose precursor cells, wherein the medium promoting the differentiation of adipose precursor cells consists of the following components and amounts: the basal medium high-sugar DMEM contains 5 mu g/mL of insulin, 0.4 mu g/mL of dexamethasone, 0.5mmol/L of IBMX, 1 mu mol/L of rosiglitazone, 150 mu mol/L of sodium oleate and 10% of fetal bovine serum by volume of the basal medium.
The maintenance differentiation culture medium for promoting pig fat precursor cell differentiation comprises the following components in parts by weight: the basal medium high-sugar DMEM contains 5 mu g/mL of insulin, 1 mu mol/L of rosiglitazone, 150 mu mol/L of sodium oleate and 10% of fetal bovine serum based on the volume of the basal medium.
Example 3 adipogenic differentiation Medium for promoting differentiation of porcine fat precursor cells wherein the Medium comprises basal medium high glucose DMEM containing 5 μg/mL insulin, 0.2 μg/mL dexamethasone, 0.3 mmol/L IBMX, 1 μmol/L rosiglitazone, 100 μmol/L sodium oleate and 8% fetal bovine serum based on basal medium DMEM volume.
A maintenance differentiation medium for promoting pig fat precursor cell differentiation, the medium comprising basal medium high sugar DMEM containing 5 μg/mL insulin, 1 μmol/L rosiglitazone, 100 μmol/L sodium oleate and 8% fetal bovine serum based on basal medium high sugar DMEM volume.
Example 4 adipogenic differentiation Medium for promoting differentiation of porcine fat precursor cells comprising basal medium high glucose DMEM containing insulin 10 μg/mL, glucocorticoid 0.8 μg/mL, IBMX0.6 mmol/L, rosiglitazone 5 μmol/L, sodium oleate 200 μmol/L and 5% fetal bovine serum based on basal medium high glucose DMEM volume.
A maintenance differentiation medium for promoting pig fat precursor cell differentiation, the medium comprising basal medium high sugar DMEM containing insulin 10 μg/mL, rosiglitazone 5 μmol/L, sodium oleate 200 μmol/L and 5% fetal bovine serum based on basal medium high sugar DMEM volume.
Example 5 methods for isolation, identification and differentiation of porcine fat precursor cells.
In this example, porcine adipose tissue was minced to 1 mm using an ophthalmic scissors 3 Then adding type I collagenase for digestion, then sieving cells, and centrifuging to obtain the pig fat precursor cells. The fat precursor cells of pigs were found to be irregularly long fusiform, triangular, etc. by microscopic observation (fig. 1). The obtained pig fat precursor cells are identified by adopting a cell immunofluorescence method, and the result shows that almost all cells express PREF1 protein (marker protein of fat precursor cells), which indicates that the pig fat precursor cells are successfully separated (figure 2), and materials are provided for researching the in vitro differentiation of the pig fat precursor cells; the specific method comprises the following steps:
the isolation procedure for pig fat precursor cells was as follows:
(1) Killing piglets after anesthesia;
(2) Transferring the piglet bodies into a biosafety cabinet subjected to ultraviolet sterilization treatment, and wiping the whole body with 75% alcohol for sterilization;
(3) Separating the neck subcutaneous fat using a sterile scalpel, an ophthalmic scissors and an ophthalmic forceps;
(4) Subcutaneous fat was rinsed in 75% alcohol and then transferred to PBS solution;
(5) Removing macroscopic blood vessels, muscle and other impurities to obtain pig subcutaneous fat, and shearing the subcutaneous fat into pieces of about 1 mm 3 Ground meat emulsion of size;
(6) Adding 5 times volume of 2 mg/mL type I collagenase solution into a centrifuge tube containing minced meat; transferring to a dissociation tube;
(7) The dissociation tube is dissociated by a tissue dissociator and then is placed in a water bath kettle at 37 ℃ for digestion for 60 min, and the dissociation tube is dissociated once every 15 min;
(8) The digestion was stopped by adding an equal volume of complete medium (high-sugar DMEM with 10% fetal bovine serum) and filtered through a 100 μm cell sieve;
(9) Centrifuging the digestive juice at a speed of 1,000 rpm for 8 min at normal temperature; discarding the supernatant, and retaining the cell pellet;
(10) Adding 3 times volume of red blood cell lysate (ACK Lysis Buffer) into the cell sediment for resuspension, performing room temperature pyrolysis for 10 min, centrifuging, discarding the supernatant, and reserving the cell sediment; standing at room temperature without ice bath;
(11) Cells were resuspended in high-carbohydrate DMEM containing 20% FBS, counted and plated at appropriate cell densities on 10 cm cell culture dishes, and after passaging, 10% FBS in high-carbohydrate DMEM was used as complete medium.
Identifying the fat precursor cells obtained in the step one by adopting immunofluorescence technology; immunofluorescence of cells using PREF1 as primary antibody to characterize the fat precursor cells in step one, immunofluorescence of porcine fat precursor cells was identified as follows:
(1) Inoculating cells into 24-well cell culture plates on the first day;
(2) The next day, the medium was discarded and washed 3 times with PBS, 300. Mu.L of cell fixative was added to the wells and the wells were fixed for 15 min. Discarding the fixing solution, washing with PBS for 3 times, each time for 5 min;
(3) Adding 0.1 PBSTr for cell permeation for 15 min, discarding the PBSTr, and washing with PBS for 3 times each for 5 min;
(4) 300. Mu.L of 0.2% BSA was added and blocked at room temperature for 60 min;
(5) Removing the blocking solution, adding 200 mu L of diluted PREF1 primary antibody (rabbit source) in a dilution ratio of 1:50-1:100, and standing at 4 ℃ overnight; washing with PBS for 3 times, each time for 5 min;
(6) 200. Mu.L of diluted goat anti-rabbit secondary antibody (dilution ratio 1:100-1:200) is added, and the mixture is incubated at room temperature for 1 h;
(7) Washing with PBS for 5 min for 3 times, diluting 100. Mu.L of 2. Mu.g/mL DAPI to 1. Mu.g/mL with PBS, and adding 200. Mu.L of staining solution into the wells for nuclear staining;
(8) PBS was washed 3 times for 5 min each, after which it was observed with a fluorescence microscope and photographed.
Example 6 screening of methods for promoting adipogenic differentiation of fat precursor cells
The steps of adipogenic induced differentiation of pig fat precursor cells are as follows;
(1) Inoculating cells into a 6-well plate for two-dimensional culture;
(2) The confluence of the pig fat precursor cells reaches 100 percent, and the pig fat precursor cells are continuously cultured for 2 d;
(3) The original complete culture medium is changed into a lipid differentiation culture medium, and induced differentiation culture is carried out on 2 d;
(4) Changing to a maintenance differentiation culture medium, and maintaining differentiation culture 2 d;
(5) Changing to complete culture medium, continuing culturing for 4 d, and changing culture medium every 2 days;
(6) The images were observed and photographed using a general microscope.
Wherein the components in the adipogenic differentiation medium are high-sugar DMEM, insulin, dexamethasone, IBMX, rosiglitazone, sodium oleate and 2% or 10% fetal bovine serum, and the components in the maintenance differentiation medium are high-sugar DMEM, insulin, sodium oleate, rosiglitazone and 2% or 10% FBS; complete medium was 10% FBS in high-sugar DMEM.
In this example, under otherwise identical conditions, 4 adipocyte inducer combinations and 2 serum concentrations were compared, each: (1) Cocktail (Cocktail method), sodium oleate and 2% FBS; (2) Cocktail, sodium oleate, RSG (rosiglitazone) and 2% fbs; (3) Cocktail and 2% FBS; (4) 2% FBS of Cocktail, RSG; (5) Cocktail, sodium oleate, and 10% FBS; (6) Cocktail, sodium oleate, RSG and 10% FBS; (7) Cocktail and 10% FBS; (8) Cocktail, RSG and 10% FBS.
As shown in FIGS. 7 and 8, the effect of inducing differentiation by serum at a high concentration was good in the case of the same inducer, whereas the effect of cell differentiation was good in the case of using the cocktail method in combination with sodium oleate and rosiglitazone at the same concentration. Namely, the "Cocktail, sodium oleate, 10% FBS of RSG" group was most effective in differentiation.
The adipogenic differentiation medium is: high sugar dmem+cocktail+sodium oleate+rsg+10% fbs; the maintenance differentiation medium was: high sugar dmem+ins (insulin) +sodium oleate+rsg+10% fbs. Wherein, insulin in the adipogenic differentiation medium is 5 mug/mL, dexamethasone is 0.4 mug/mL, IBMX is 0.5mmol/L, rosiglitazone is 1 mug/L, sodium oleate is 150 mug/L; insulin 5. Mu.g/mL, rosiglitazone 1. Mu. Mol/L, sodium oleate 150. Mu. Mol/L in the differentiation medium was maintained.
EXAMPLE 7 identification of mature adipocytes and expression of differentiation-related Gene
The method of staining adipocytes generally includes oil red O staining, BODIPY staining, and the like. In addition, the observation can be directly performed without dyeing.
Oil red O is a fat-soluble dye that is highly soluble in fat and specifically colors neutral fats such as intracellular triglycerides. BODIPY is a near infrared short wavelength fluorescent dye that acts specifically on oil droplets composed of neutral lipids.
In the present invention, direct observation and staining of undifferentiated (0 d) and differentiated 8 d (10% FBS composition using Cocktail, sodium oleate, RSG) cells were performed using the direct observation method and three methods of oil red O staining and BODIPY staining.
As a result, as shown in FIG. 3, vacuolated lipid droplets were observed in cells differentiated by 8 d, and after staining, these lipid droplets were stained with oil red O to bright red and BODIPY to green, indicating that the adipogenic differentiation method using the 10% FBS composition of "Cocktail, sodium oleate, RSG successfully promoted adipogenic differentiation of pig fat precursor cells into mature adipocytes.
The core component of the lipid droplets is triglyceride, the invention collects the fat cells differentiated by 0 d and 8 d, and the triglyceride content is determined by using a cell triglyceride determination kit.
The results are shown in figure 4, where the content of Triglycerides (TAGs) in differentiated 8 d cells is significantly increased compared to undifferentiated fat precursor cells (0 d). The specific detection method is shown in a kit (product number E1013) for measuring the Triglyceride (TG) content of the Prilet tissue cells by an enzyme method.
According to the invention, adipocytes differentiated by 0 d, 2 d, 4 d, 6 d and 8 d are collected, total cell proteins are extracted, expression of PREF1, ADIPOQ, FABP4, PPARgamma and CEBP alpha is detected by a Western blot technology, and TUBB and ACTB are used as internal references at the same time.
As a result, as shown in FIG. 5, the expression level of precursor adipocyte DLK1 was gradually decreased from 2 d, and the expression level was very weak in the cells differentiated by 8 d, which was consistent with the expected result. Whereas the expression of ADIPOQ, FABP4, pparγ, cebpα gradually increased with the differentiation expression amount, FABP4 peaked as a marker of terminal differentiation at day 8 of differentiation, as shown in fig. 4. The detection method comprises the following steps:
mature adipocyte oil red O staining was used as follows:
(1) Discarding the culture solution, and adding PBS to gently rinse for 1 time;
(2) Adding cell fixing solution, fixing for 10 min, and rinsing with PBS for 2 times;
(3) Adding a proper amount of staining washing liquid to cover the cells 20 and s;
(4) Discarding the dyeing washing liquid, adding a proper amount of modified oil red O dyeing liquid, and dyeing for 15 min in a dark place;
(5) Discarding the modified oil red O staining solution, adding a proper amount of staining washing solution, and standing for 30 s;
(6) The staining wash was discarded, washed with PBS 20 s, observed under a mirror and photographed.
Dyeing with BODIPY dye liquor, wherein the steps are as follows:
(1) The culture broth was discarded and rinsed 1 time with PBS;
(2) Adding cell fixing solution, fixing for 10 min, and rinsing with PBS for 3 times;
(3) Adding 5 mu mol/L BODIPY working solution and 5 mu g/mL DAPI solution, and dyeing for 10 min in dark;
(4) Discarding the staining solution, rinsing with PBS for 3 times, each time for 5 min;
(5) Observed under a fluorescence microscope and photographed.
Cell protein extraction:
(1) Discarding the culture solution, and adding PBS for rinsing for 1 time;
(2) Adding appropriate amount of cell lysate (300 μl per well of 6-well plate) containing protease inhibitor, and standing on ice for 10 min;
(3) Scraping the cells from the bottom of the hole from left to right by scraping the cells from top to bottom, and blowing and uniformly mixing the cells by using a pipetting gun;
(4) The cell lysate was collected in a 1.5 mL centrifuge tube and centrifuged at 12,000 rpm at 4℃for 30 min;
(5) Transferring the supernatant to a new 1.5 mL centrifuge tube, placing the supernatant, namely the protein, at-80 ℃ for later use.
Western blot:
(1) Taking out the protein in a refrigerator at-80deg.C, thawing on ice, mixing 20 μL of protein with 5 μL of 5×protein loading buffer solution, boiling at 100deg.C for 10 min to denature the protein;
(2) Preparing 10% -12% SDS-PAGE gel;
(3) 10 mu L of denatured protein is added to each lane, and 5 mu L of pre-dyed protein Marker is reserved in one lane;
(4) Setting 120V electrophoresis conditions, and performing electrophoresis for 15 min and 200V electrophoresis for 40 min until bromophenol blue indicator strips migrate to about 1 cm from the lower end of gel, and stopping electrophoresis;
(5) Setting constant current 400 and mA by using a wet transfer method, and transferring for about 30 minutes to a PVDF film;
(6) Placing the PVDF membrane into an antibody incubation box containing a sealing solution, wherein the room temperature is 1 h;
(7) The sealing liquid is used for sealing according to the proportion of 1: diluting the primary antibody at 5000, adding the primary antibody into an antibody incubation box, and incubating overnight at 4 ℃;
(8) TBST washes the membrane for 3 times, each time for 10 min;
(9) The following is 1 with TBST: diluting the secondary antibody at 5000, adding the secondary antibody into an antibody incubation box, and incubating at room temperature for 1 h;
(10) TBST washes the membrane for 3 times, each time for 10 min;
(11) Detection was performed with ECL chemiluminescent solution and observations and photographs were taken using a chemiluminescent imaging system.
EXAMPLE 8 application of pig fat precursor cell adipogenic differentiation in three-dimensional culture
The three-dimensional culture of cells is more similar to the physiological environment in vivo than the traditional two-dimensional culture. The lipid-forming differentiation medium comprising "high sugar DMEM, cocktail, sodium oleate, RSG and 10% fbs" was added to the three-dimensional culture roller bottle, and after 2 days, the differentiation method of changing the composition comprising "high sugar DMEM, INS, sodium oleate, RSG and 10% fbs" maintenance differentiation medium was applied to the three-dimensional culture. Upon BODIPY staining, it was found that adipogenic differentiation of fat precursor cells into mature adipocytes was successful also in the case of three-dimensional culture (fig. 6). The pig fat precursor cell differentiation method is applicable to two-dimensional and three-dimensional culture.
The specific method for three-dimensionally culturing the pig fat precursor cells into lipid differentiation is as follows:
(1) Inoculating cells into a roller bottle, 10 5 cell/mL medium, 1 piece microcarrier/10 mL medium, rotation speed set at 25 rpm,10 min;0 rpm,50 min,24 cycles, followed by a rotational speed set to 30 rpm;
(2) After the cells are full, culturing is continued for 2 d;
(3) Changing the complete culture medium into a lipid differentiation culture medium, and inducing differentiation culture 2 d;
(4) Changing to a maintenance differentiation culture medium, and maintaining differentiation culture 2 d;
(5) Changing to complete culture medium, continuing culturing for 4 d, and changing culture medium every 2 days;
the application of the culture medium is characterized in that the adipogenic differentiation culture medium and the maintenance differentiation culture medium are applied, and the steps are as follows:
(1) The confluence of animal fat precursor cells reaches 100 percent, and the culture is continued for 2 d;
(2) Discarding the old culture medium, and adding a adipogenic differentiation culture medium to induce differentiation 2 d;
(3) Removing the adipogenic differentiation medium, and adding a maintenance differentiation medium to maintain differentiation culture 2 d;
(4) The differentiation maintaining culture medium is discarded, a complete culture medium is added, and the culture is continued for 4 d, and the culture medium is replaced every 2 d;
(5) Observed using a microscope and photographed.
Fat drop BODIPY staining
(1) Sucking 1 mL cell suspension, settling the cells together with the microcarriers, discarding the supernatant medium, and rinsing once with PBS;
(2) Adding cell fixing solution, fixing for 10 min, and rinsing with PBS for 2 times;
(3) Adding proper amount of 5 mu mol/L BODIPY working solution and DAPI (simultaneously dying cell nuclei) to cover cells and dyeing for 10 min in dark;
(4) Discarding the staining solution, washing with PBS for 3 times, each time for 5 min;
(5) The photographs were scanned using a high content cell imaging system.
Example 9 otherwise as in example 5, wherein: in the step of separating pig fat precursor cells:
(6) Adding 5 times volume of type I collagenase solution of 1 or 3 mg/mL into a centrifuge tube containing minced meat, and transferring to a tissue dissociation tube;
(7) The tissue dissociation tube is dissociated by a tissue dissociation device and then is placed in a water bath kettle at 37 ℃ for digestion for 60 or 90 min, and the tissue dissociation device is used for dissociation once every 20 min;
(8) The digestion was stopped by adding an equal volume of complete medium (high-sugar DMEM with 10% fetal bovine serum) and filtered through a 70 or 150 μm cell sieve;
(9) Centrifuging the digestive juice at 800 or 1500 rpm for 5 or 10 min at normal temperature; discarding the supernatant, and retaining the cell pellet;
(10) Adding red blood cell lysate (ACK Lysis Buffer) with the volume of 5 times of that of the minced meat into the cell sediment for resuspension, performing centrifugation after 5 or 8 min of room temperature pyrolysis, discarding the supernatant, reserving the cell sediment, and standing at room temperature without ice bath;
(11) Cells were resuspended in high-carbohydrate DMEM containing 20% FBS, counted and plated at appropriate cell densities on 10 cm cell culture dishes, and passaged using 10% FBS-containing high-carbohydrate DMEM as complete medium.
The immunofluorescence identification steps of the pig fat precursor cells are as follows:
(1) Inoculating cells into 24-well cell culture plates on the first day;
(2) The next day, the medium was discarded, washed 3 times with PBS, 400 or 500. Mu.L of cell fixative was added to the wells, and fixation was performed for 15 min; discarding the fixing solution, washing with PBS for 2 or 4 times, each for 5 min;
(3) Adding 0.1-1% PBSTr for cell permeation for 20 min, discarding PBSTr, and washing with PBS for 2 or 4 times for 5 min each time;
(4) Adding 400 or 500 mu L of 0.2-2% BSA, and blocking at room temperature for 45 or 50 min;
(5) Discarding the blocking solution, adding 100-200 mu L of diluted PREF1 primary antibody (rabbit source) in the dilution ratio of 1:50-1:100, and standing at 4 ℃ overnight; PBS is washed for 2 or 4 times, each time for 5 min;
(6) Adding 100-200 mu L of diluted goat anti-rabbit secondary antibody (dilution ratio is 1:1000-1:200), and incubating at room temperature for 2 h;
(7) Washing with PBS for 2 or 4 times, each for 5 min, diluting 150 or 200 mu L of 1 or 5 mu g/mL DAPI to 1 mu g/mL with PBS, and adding 200 mu L of staining solution into the hole for cell nucleus staining;
(8) PBS was washed 2 or 4 times, 5 min each, after which it was observed with a fluorescence microscope and photographed.
The above does not mention the specific name of the medium, the complete medium, and the detection device used is a conventional device or instrument.
The above examples/experiments are only examples for clarity of illustration and are not limiting of the embodiments. Other variations or modifications of the above teachings will be apparent to those of ordinary skill in the art. It is not necessary here nor is it exhaustive of all embodiments. While still being apparent from variations or modifications that may be made by those skilled in the art are within the scope of the invention.
Claims (10)
1. A method for the isolation, identification and adipogenic differentiation of mammalian adipose precursor cells, characterized in that: the method comprises the following steps:
step one, isolating mammalian fat precursor cells: using a mechanical method in combination with a collagenase digestion method;
step two, identifying the mammalian fat precursor cells: using cellular immunofluorescence;
step three, promoting in vitro induced differentiation of the mammalian fat precursor cells: differentiating fat precursor cells into mature fat cells by a combination of multiple adipogenic inducers;
step four, identifying mature adipocytes of the mammal: identification was performed using oil red O staining, BODIPY staining, TAG assay and/or Western blot techniques.
2. A method for the isolation, identification and adipogenic differentiation of mammalian adipose precursor cells according to claim 1, wherein: the step one of separating the pig fat precursor cells specifically comprises the following steps:
(1) Obtaining subcutaneous fat of mammals, cutting into minced meat, adding 1-3 mg/mL collagenase solution, transferring to a tissue dissociation tube, dissociating by using a tissue dissociation device, placing in a water bath kettle at 37 ℃, digesting for 60-90 min, and dissociating once every 15-20 min; adding an equal volume of high-sugar DMEM containing 10% fetal bovine serum, stopping digestion, and filtering with a cell sieve of 70-150 μm; preferably, filtration is performed with a 100 μm cell sieve; the volume and dosage ratio of the minced meat to the collagenase solution is 1:5, a step of;
(2) Centrifuging the digestive juice at 800-1500 rpm at normal temperature for 5-10 min, discarding supernatant, and retaining cell precipitate; preferably, the digest is centrifuged at 1000 rpm for 8 minutes at ambient temperature;
(3) Adding 3-5 times of volume of red blood cell lysate of minced meat into the cell sediment for resuspension, performing room temperature pyrolysis for 5-10 min, centrifuging, discarding supernatant, and reserving the cell sediment; preferably, the ice bath is not performed at room temperature;
(4) Cell pellets were resuspended in high-carbohydrate DMEM containing 20% FBS and inoculated into cell culture dishes, and after passaging, high-carbohydrate DMEM containing 10% FBS was used as complete medium.
3. A method for the isolation, identification and adipogenic differentiation of mammalian adipose precursor cells according to claim 1, wherein: the second step is to identify the fat precursor cells obtained in the first step by adopting immunofluorescence technology; preferably, the fat precursor cells in step one are characterized by cellular immunofluorescence using PREF1 as primary antibody; further preferably, the method specifically comprises the following steps:
(1) Inoculating cells into 24-well cell culture plates on the first day;
(2) The next day, the culture medium is discarded, after PBS washing, 300-500 mu L of cell fixing solution is added for fixing for 10-30 min, the fixing solution is discarded, and PBS is used for washing for 2-4 times;
(3) Adding 0.1% -1% PBSTr for cell permeation for 15-20 min, discarding PBSTr, and washing with PBS for 2-4 times;
(4) Adding 300-500 mu L of 0.2% -2% BSA, and sealing for 45-60 min at room temperature;
(5) Discarding the blocking solution, adding 100-200 mu L of PREF1 primary antibody, standing at 4 ℃ for incubation overnight, and washing with PBS for 2-4 times; preferably, the dilution ratio of the primary antibody is 1:50-1:100;
(6) Adding 100-200 mu L goat anti-rabbit secondary antibody, and incubating at room temperature for 1-2 h; preferably, the dilution ratio of the secondary antibody is 1:100-1:200;
(7) PBS (phosphate buffer solution) is used for washing for 2-4 times, 100-200 mu L of 1-5 mu g/mL DAPI staining solution is added for cell nucleus staining;
(8) After washing 2-4 times with PBS, observation was performed by using a fluorescence microscope and photographing was performed.
4. A method for the isolation, identification and adipogenic differentiation of animal fat precursor cells according to claim 1, characterized in that: the third step specifically comprises the following steps:
(1) Inoculating cells into a 6-well plate for two-dimensional culture; or inoculating the cells into a roller bottle 10 5 cell/mL medium, 1 piece microcarrier/10 mL medium, rotation speed set at 25 rpm,10 min;0 rpm,50 min,24 cycles, and then the rotation speed is set to be 30 rpm, and three-dimensional culture is carried out;
(2) After the cells are full, culturing is continued for 2 d;
(3) Changing the culture medium into a lipid differentiation culture medium, and inducing differentiation culture 2 d;
(4) Changing to a maintenance differentiation culture medium, and maintaining differentiation culture 2 d;
(5) Changing to complete culture medium, continuously culturing for 4 d, and changing culture solution every 2 days;
wherein the components in the adipogenic differentiation medium comprise high glucose DMEM, insulin, glucocorticoid, IBMX, thiazolidinedione reagent, fatty acid sodium and 2-10% fetal bovine serum, and the components in the differentiation medium comprise high glucose DMEM, insulin, fatty acid sodium, thiazolidinedione reagent and 2-10% FBS; preferably, the thiazolidinedione is one of troglitazone and rosiglitazone, and/or the fatty acid sodium is sodium oleate, and/or the glucocorticoid is one of dexamethasone or hydrocortisone.
5. A method for the isolation, identification and adipogenic differentiation of mammalian adipose precursor cells according to claim 1, wherein: identifying the mature adipocytes differentiated in the fourth step through oil red O staining, BODIPY staining, TAG content measurement and/or Western blot technology; preferably, the differentiated adipocytes are collected, the total cell proteins are extracted, and the expression of differentiation marker proteins ADIPOQ, FABP4, PPARgamma and CEBP alpha is detected by a Western blot technique, and TUBB and ACTB are used as internal references at the same time; preferably, the dyeing with BODIPY comprises the following steps:
(1) Discarding the culture solution, and rinsing with PBS for 1-2 times;
(2) Adding cell fixing solution, fixing for 10-30 min, and rinsing with PBS for 2-4 times;
(3) Adding proper 1-5 mu mol/L BODIPY working solution and 1-5 mu g/mL DAPI solution to dye for 10-15 min in dark place;
(4) Discarding the staining solution, and rinsing with PBS for 3 times;
(5) Observed using a fluorescence microscope and photographed.
6. A composition for the isolation, identification and adipogenic differentiation of mammalian adipose precursor cells, characterized in that: the composition comprises insulin, IBMX, a glucocorticoid, sodium fatty acid and a thiazolidinedione; preferably, the thiazolidinedione is one of troglitazone and rosiglitazone, and/or the fatty acid sodium is sodium oleate, and/or the glucocorticoid is one of dexamethasone or hydrocortisone; or the composition is composed of insulin, IBMX, dexamethasone, sodium oleate, and rosiglitazone.
7. A adipogenic differentiation medium for promoting differentiation of mammalian adipose precursor cells, characterized in that: the culture medium comprises basic culture medium high glucose DMEM, insulin 5-10 mu g/mL, glucocorticoid 0.2-0.8 mu g/mL, IBMX0.3-0.6 mmol/L, rosiglitazone 1-5 mu mol/L, sodium oleate 100-200 mu mol/L and 2-10% fetal bovine serum; preferably, insulin is 5. Mu.g/mL, glucocorticoid is 0.4. Mu.g/mL, IBMX is 0.5mmol/L, thiazolidinedione is 1. Mu. Mol/L, sodium fatty acid is 150. Mu. Mol/L and 2-10% fetal bovine serum; further preferably, the fetal bovine serum is 10%.
8. A maintenance differentiation medium for promoting differentiation of mammalian adipose precursor cells, characterized in that: the culture medium comprises a basal medium high-sugar DMEM, and contains 5-10 mu g/mL of insulin, 1-5 mu mol/L of rosiglitazone, 100-200 mu mol/L of sodium oleate and 2-10% of fetal bovine serum; preferably, insulin is 5. Mu.g/mL, thiazolidinedione is 1. Mu. Mol/L, sodium fatty acid is 150. Mu. Mol/L and 2-10% fetal bovine serum; further preferably, the fetal bovine serum is 10%.
9. Use of the medium according to claim 7 or 8, characterized in that: the adipogenic differentiation medium and the maintenance differentiation medium are applied, comprising the steps of:
(1) Mammalian fat precursor cells reached 100% confluence and continued to be cultured 2 d;
(2) Discarding the old culture medium, and adding a adipogenic differentiation culture medium to induce differentiation 2 d;
(3) Removing the adipogenic differentiation medium, and adding a maintenance differentiation medium to maintain differentiation culture 2 d;
(4) The differentiation maintaining culture medium is discarded, a complete culture medium is added, and the culture is continued for 4 d, and the culture medium is replaced every 2 d;
(5) The images were observed and photographed using a general microscope.
10. The composition as recited in claim 6, wherein: use of insulin, glucocorticoid, IBMX, thiazolidinedione and sodium fatty acid for the preparation of a medicament or composition for the prevention, alleviation and/or treatment of lipodystrophy, medicament for the regulation of fat development and metabolism; preferably, the thiazolidinedione is one of troglitazone and rosiglitazone, and/or the fatty acid sodium is sodium oleate, and/or the glucocorticoid is one of dexamethasone or hydrocortisone.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311756120.XA CN117625527A (en) | 2023-12-20 | 2023-12-20 | Method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, composition and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311756120.XA CN117625527A (en) | 2023-12-20 | 2023-12-20 | Method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, composition and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117625527A true CN117625527A (en) | 2024-03-01 |
Family
ID=90026898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311756120.XA Pending CN117625527A (en) | 2023-12-20 | 2023-12-20 | Method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, composition and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117625527A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000157260A (en) * | 1998-11-26 | 2000-06-13 | Toyobo Co Ltd | Differentiation induction of primary precursor adipose cell, and culture medium for its differentiation |
CN107858327A (en) * | 2017-12-20 | 2018-03-30 | 河南农业大学 | Separation, culture and the method for inducing differentiation of the intramuscular Preadipocyte In Vitro of one breeder |
US20200277575A1 (en) * | 2017-11-16 | 2020-09-03 | Nissan Chemical Corporation | Method for inducing differentiation into and producing beige and white adipocytes |
CN113717932A (en) * | 2021-09-16 | 2021-11-30 | 四川农业大学 | Primary isolation culture and induced differentiation method for intramuscular precursor adipocytes of adult yaks |
CN116970553A (en) * | 2022-04-21 | 2023-10-31 | 中国农业科学院兰州畜牧与兽药研究所 | Preparation method of yak precursor fat cells |
-
2023
- 2023-12-20 CN CN202311756120.XA patent/CN117625527A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000157260A (en) * | 1998-11-26 | 2000-06-13 | Toyobo Co Ltd | Differentiation induction of primary precursor adipose cell, and culture medium for its differentiation |
US20200277575A1 (en) * | 2017-11-16 | 2020-09-03 | Nissan Chemical Corporation | Method for inducing differentiation into and producing beige and white adipocytes |
CN107858327A (en) * | 2017-12-20 | 2018-03-30 | 河南农业大学 | Separation, culture and the method for inducing differentiation of the intramuscular Preadipocyte In Vitro of one breeder |
CN113717932A (en) * | 2021-09-16 | 2021-11-30 | 四川农业大学 | Primary isolation culture and induced differentiation method for intramuscular precursor adipocytes of adult yaks |
CN116970553A (en) * | 2022-04-21 | 2023-10-31 | 中国农业科学院兰州畜牧与兽药研究所 | Preparation method of yak precursor fat cells |
Non-Patent Citations (3)
Title |
---|
(法)伊鲁士,(巴西)斯泰罗迪马斯编著: "脂肪干细胞与再生医学", 30 April 2015, 北京:人民军医出版社, pages: 56 * |
WEN-JUAN SONG 等: ""Identification of porcine adipose progenitor cells by flurescence-activated cell sorting for the preparation of cultured fat by 3D bioprinting"", 《FOOD RESEARCH INTERNATIONAL》, vol. 162, 19 September 2022 (2022-09-19), pages 3 * |
郑燕: ""外源油酸促进牛脂生成的初步研究"", 《中国优秀硕士学位论文全文数据库 农业科技辑》, 15 January 2023 (2023-01-15), pages 050 - 277 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2710373C2 (en) | Composition comprising exosomes prepared from stem cells for induction of adipogenic differentiation, regeneration of adipose tissue, skin bleaching or wrinkle correction | |
US11339372B2 (en) | Serum-free medium inducing differentiation of umbilical cord mesenchymal stem cell into insulin-secretion-like cell and preparation method and use thereof | |
CN112352047A (en) | Preparation method and application of exosome derived from human umbilical cord mesenchymal stem cells | |
CN103930542A (en) | Brown fat cell compositions and methods | |
CN101748096A (en) | Sub totipotential stem cell and preparation method and application thereof | |
CN109136174B (en) | Stem cell-derived exosome preparation for delaying senescence | |
KR101753630B1 (en) | Composition for promoting the differentiation of stem cell and proliferation of cell and the method of manufacturing the same | |
KR20150129726A (en) | Cell repopulated collagen matrix for soft tissue repair and regeneration | |
CN105267243B (en) | Stem cell extract for eliminating skin striae gravidarum | |
Tan et al. | Retinoic acid promotes the proliferation of primordial germ cell–like cells differentiated from mouse skin-derived stem cells in vitro | |
US20240315294A1 (en) | Methods and processes for culturing cells | |
CN109852581A (en) | A kind of method for promoting stem cell to break up at rouge and its agents useful for same or kit | |
CN106282103A (en) | Animal mescenchymal stem cell immunosuppressant can strengthen serum-free medium | |
CN117625527A (en) | Method for separating, identifying and adipogenic differentiating mammalian fat precursor cells, composition and application | |
CN102703380B (en) | Sub-totipotent stem cell, preparation method and application thereof | |
CN109182256A (en) | A kind of spotted maigre Preadipocyte In Vitro be separately cultured and its abductive approach | |
KR20150091519A (en) | A method of generating multilineage potential cells | |
KR101738715B1 (en) | Method for derivation of pluripotent stem cells using plant stem cells or callus extracts, and pluripotent stem cells produced using the same | |
CN104130975B (en) | The neuron cell and its preparation method and application in human adipose-derived stem cells source | |
AU2009317191A1 (en) | Myometrial-derived mesenchymal stem cells | |
CN117487745B (en) | Pigeon fat precursor cell separation and in-vitro culture method, culture and application | |
CN116590225B (en) | Application of phosphatidylcholine in preparation of preparation for promoting pig FAPs cell differentiation polyester | |
CN110592008A (en) | Method for culturing bone marrow mesenchymal stem cells of canine animals | |
Hong et al. | Myogenesis of Porcine Muscle Satellite Cells by Extracellular Matrix From Fibrotic Adipose Tissue-Derived Mesenchymal Stem Cells | |
CN117757724B (en) | Cardiopulmonary progenitor cell exosome and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |